“Of course we’re all excited about the upcoming vaccines; they can’t come soon enough, and we need to vaccinate everyone as soon as we can,” said Northwestern’s Shuai (Steve) Xu. “But, it will still take time to distribute those. Here in the United States, we are approaching 200,000 new cases and 1,500 deaths each day. This means that millions of people will still get infected until a vaccine comes. So, we need to stay vigilant.

“Furthermore, in the time of COVID-19, we forget other killers,” Xu added. “These sensors and the algorithms that we will develop could be applied to…


Citizen App SafePass Uses Phosphorus Test Results to Allow Individuals to Monitor Whether They Have Been Potentially Exposed to COVID-19, Up to 10,000 Free Tests Are Available All Information Is Private and Opt-In Only; No Identities Are Released and Personal Information Is Never Shared

New York, NY, August 25, 2020 — Phosphorus, a leading genomics firm headquartered in New York City with a laboratory in New Jersey that has an FDA Emergency Use Authorization for in-home saliva-based COVID-19 testing, announced today that its tests are available on the Citizen App — an app that allows individuals to track symptoms, find…


Co-Founder and CEO of Phosphorus Alexander Bisignano believes that working with specialists and patients and teaching them his technology is what sets his organization apart.

DNAWeekly: What is Phosphorus’ mission?

Alexander Bisignano: Phosphorus is a genomics company whose mission is to improve human health. Phosphorus is a spin-out from my previous company called Recombine which had worked in the reproductive genetics field. One of the fundamental issues that we identified when we started the company is that access to genetic testing and application of genetic testing in medicine is, in some ways, extremely limited. Fewer than 4% of the US population has reported actually ever…


The topic of genetics is one that has come up more than ever before. With new breakthroughs in genetic interpretation, we’re able to provide more insight into our ancestry, health history and what may lie ahead for us in terms of what diseases or conditions we have a predisposition for.

One of the things we are asked often at Phosphorus is why would someone use Phosphorus if they are otherwise healthy? Especially when there is a common perception that you can’t do anything to change it.

We disagree.

Our goal is to help you stay healthy by understanding your genetic…


The Phosphorus ONE genetic test is the first genetic test that looks into the understood genetics of sleep. Discover if you are a deeper or lighter sleeper, why you might be a night owl or morning person, and whether you simply need more or less hours than the average person.

What can my genes tell me about my sleep patterns?

Sleep is an essential function for all of us. While we spend > 33% of our lives in our bed, sleep is sadly an often overlooked part of our annual health check-ups. …


October is Pregnancy and Infant Loss Awareness month. This is a time to recognize families and individuals who have suffered a pregnancy loss. According to the March of Dimes, a nonprofit organization that works to improve the health of mothers and babies, as many as 50% of all pregnancies end in miscarriage. Of those losses, approximately 50% of first trimester miscarriages are due to a chromosome abnormality in the fetus. When it comes to both fertility concerns and miscarriages, many don’t realize genetics can offer valuable insight. …


Last month, Phosphorus attended the American Society of Human Genetics (ASHG) 2018 Annual Meeting in San Diego, California. The ASHG Meeting is an important event for Phosphorus, allowing us to see what is new in the wider world of genetics and to get a better sense of those whom we are helping with our products and services. Phosphorus was proud to present its poster, entitled “CtsCNV: A Copy Number Variant Detection Method for Clinical Targeted Sequencing Data.” The poster provided details on our attempt to develop an algorithm using clinical NGS data to better detect copy number variants (CNVs). …


A breakdown of our algorithm for identifying the SMN1 and SMN2 counts computationally from FASTQ files

Spinal Muscular Atrophy is an autosomal recessive muscular disease that causes progressive muscular degradation and weakness. SMA often leads to an early death, most commonly in infants with the most severe form. It has an estimated incidence of 1/10,000 and a carrier frequency of 1 in 40 to 1 in 60.

SMA is caused by the deficiency of the motor neuron protein SMN (Survival Motor Neuron). The SMN protein is encoded by the SMN1 and SMN2 genes. The number of copies of these genes…


Hi Jasmine! Very happy to be speaking with you today. Can you tell me a little about your role at the SADS Foundation and your background in volunteering and helping patient communities?

___


Though Children’s Cardiomyopathy Awareness Month (CCAM) has passed, the need for disease awareness never expires. Phosphorus greatly enjoyed partnering with the Children’s Cardiomyopathy Foundation for the month of September, and we want to follow-up on our collaboration to bring you additional information and resources that can help save a life.

If you have not previously encountered the concept of cardiomyopathy, this helpful one-pager from the CCF explains everything you need to know about the condition:

Phosphorus Diagnostics

Phosphorus Diagnostics is using genomics to improve human health. We offer the most comprehensive, actionable #genetic test for disease prevention.

Get the Medium app

A button that says 'Download on the App Store', and if clicked it will lead you to the iOS App store
A button that says 'Get it on, Google Play', and if clicked it will lead you to the Google Play store